BAFL 45.66 Increased By ▲ 0.56 (1.24%)
BIPL 20.08 Decreased By ▼ -0.17 (-0.84%)
BOP 5.34 Decreased By ▼ -0.06 (-1.11%)
CNERGY 4.54 Increased By ▲ 0.01 (0.22%)
DFML 16.01 Increased By ▲ 0.33 (2.1%)
DGKC 78.62 Increased By ▲ 5.74 (7.88%)
FABL 27.80 Increased By ▲ 0.65 (2.39%)
FCCL 18.86 Increased By ▲ 1.21 (6.86%)
FFL 8.96 Decreased By ▼ -0.13 (-1.43%)
GGL 12.85 Increased By ▲ 0.21 (1.66%)
HBL 111.54 Increased By ▲ 0.88 (0.8%)
HUBC 122.23 Increased By ▲ 0.71 (0.58%)
HUMNL 7.69 Increased By ▲ 0.34 (4.63%)
KEL 3.29 Increased By ▲ 0.06 (1.86%)
LOTCHEM 27.80 Increased By ▲ 0.48 (1.76%)
MLCF 42.36 Increased By ▲ 3.03 (7.7%)
OGDC 110.37 Increased By ▲ 2.37 (2.19%)
PAEL 18.97 Increased By ▲ 1.41 (8.03%)
PIBTL 5.46 No Change ▼ 0.00 (0%)
PIOC 114.91 Increased By ▲ 6.91 (6.4%)
PPL 94.72 Increased By ▲ 2.97 (3.24%)
PRL 25.32 Increased By ▲ 0.44 (1.77%)
SILK 1.10 Increased By ▲ 0.02 (1.85%)
SNGP 64.32 Increased By ▲ 1.22 (1.93%)
SSGC 12.26 Increased By ▲ 0.37 (3.11%)
TELE 8.36 Increased By ▲ 0.17 (2.08%)
TPLP 13.35 Increased By ▲ 0.24 (1.83%)
TRG 83.84 Increased By ▲ 2.23 (2.73%)
UNITY 25.89 Increased By ▲ 0.14 (0.54%)
WTL 1.54 Increased By ▲ 0.02 (1.32%)
BR100 6,308 Increased By 126.6 (2.05%)
BR30 21,973 Increased By 434.1 (2.02%)
KSE100 61,691 Increased By 1160 (1.92%)
KSE30 20,555 Increased By 366.1 (1.81%)
Markets

European stocks pause near record high, UK outperforms

  • Profits for companies on the STOXX 600 are expected to jump 47.4pc in the first quarter versus beaten-down numbers a year earlier, according to Refinitiv IBES data.
Published April 7, 2021 Updated April 8, 2021

European stocks were little changed and closed just short of record highs on Wednesday, with healthcare shares among top decliners, while optimism over speedy vaccination drives and a weaker pound helped UK equities outperform.

The pan-European STOXX 600 index edged 0.1pc lower, trading just below the record closing peak of 435.26 points on Tuesday. Healthcare stocks fell 0.8pc, leading sectoral declines.

UK's exporter-heavy FTSE 100 gained 0.9pc as a weaker pound lifted the dollar earners, while the domestically focussed midcap index hit a record high as Britain began the roll-out of Moderna's COVID-19 vaccine.

"It appears that while the UK blue chip index, and its mid-cap sibling, enjoy the optimism surrounding the country's post-COVID comeback, sterling has been saddled with concerns over the vaccine programme," said Connor Campbell, an analyst at Spreadex.

A rebound in economically sensitive sectors such as banks, energy and automakers pushed European stocks to pre-pandemic levels earlier this week, as investors bet on a strong global economic recovery, driven by vaccines and unprecedented stimulus measures.

A final reading of IHS Markit's Purchasing Managers' Index showed euro zone business activity returned to growth in March, underpinned by a record expansion in the manufacturing sector and as the service industry coped with new lockdowns better than expected.

"There is a case to be made in the second half of the year when Europe really has its moment, because it has lagged the rest in its recovery. They've finally managed to ramp up vaccine production and distribution," said Julien Lafargue, head of equity strategy at Barclays Private Bank.

With earnings season set to kick off this month, investors are hoping for a strong recovery.

Profits for companies on the STOXX 600 are expected to jump 47.4pc in the first quarter versus beaten-down numbers a year earlier, according to Refinitiv IBES data.

Recent UK market debutant Deliveroo Holdings rose 2.1pc to 285.7549 pence in its first day of unrestricted trading when retailers were allowed to trade. It has shed almost 28pc since last week when it priced its initial public offering at 390 pence.

French M&A was also in focus, with power group EDF jumping 10.5pc, after sources told Reuters the government expects to spend around 10 billion euros ($11.87 billion) to buy out minority shareholders as part of a proposed restructuring of the company.

Amundi rose 2.9pc after Societe Generale said it was in exclusive talks to sell most of asset manager Lyxor to Amundi for 825 million euros ($979 million).

Comments

Comments are closed.

European stocks pause near record high, UK outperforms

Israel's goal to destroy Hamas risks decade of war: Macron

Honour climate financing, PM asks developed world

CJP’s office says he’s ‘fully cognizant of his constitutional duties’

Expenditures: Higher mark-up payments may put big pressure: MoF

New regulatory safeguards placed to protect investors: SECP chief

BIT template issue settled: Crucial FTA with GCC finalised

David Warner included in settled Australia squad for first Pakistan Test

India's ruling BJP leads in 3 of 4 state poll results

Water supply project: Sindh govt signs Rs51.6bn contract with Kuwaiti firm

Trump calls on supporters to 'guard the vote' in Democratic-run US cities